Correction

Bok is a genuine multi-BH-domain protein that triggers apoptosis in the absence of Bax and Bak (vol 129, pg 2213, 2016)

JOURNAL OF CELL SCIENCE (2016)

期刊

JOURNAL OF CELL SCIENCE

卷 129, 期 15, 页码 3054-3054

出版社

COMPANY OF BIOLOGISTS LTD

DOI: 10.1242/jcs.193946

关键词

-

类别

Cell Biology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

推荐

Article Biochemistry & Molecular Biology

Visualization of BOK pores independent of BAX and BAK reveals a similar mechanism with differing regulation

Raed Shalaby, Arzoo Diwan, Hector Flores-Romero, Vanessa Hertlein, Ana J. Garcia-Saez

Summary: The activity and structure of BOK protein, a member of the BCL-2 family, have been investigated. It was found that the thermal stability and pore activity of BOK depend on its C-terminus and the presence of mitochondrial lipid cardiolipin. BOK pores were visualized in liposomes and apoptotic mitochondria, showing similar properties to BAX and BAK. However, BOK's apoptotic activity is limited by its partial mitochondrial localization and is independent of other BCL-2 proteins.

CELL DEATH AND DIFFERENTIATION (2023)

添加到收藏夹

Article Oncology

Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK Dependent Cell Death

Sylvain Garciaz, Andrew A. Guirguis, Sebastian Muller, Fiona C. Brown, Yih-Chih Chan, Ali Motazediani, Caitlin L. Rowe, James A. Kuzich, Kah Lok Chan, Kevin Tran, Lorey Smith, Laura MacPherson, Brian Liddicoat, Enid Y. N. Lam, Tatiana Caneque, Marian L. Burr, Veronique Litalien, Giovanna Pomilio, Mathilde Poplineau, Estelle Duprez, Sarah-Jane Dawson, Georg Ramm, Andrew G. Cox, Kristin K. Brown, David C. S. Huang, Andrew H. Wei, Kate McArthur, Raphael Rodriguez, Mark A. Dawson

Summary: Ironomycin is a drug that disrupts mitochondrial metabolism and induces cell death in cancer cells by reducing mitochondrial iron load and activating BAX/BAK. It exhibits synergy with BH3 mimetics and overcomes venetoclax resistance in cancers such as acute myeloid leukemia.

CANCER DISCOVERY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

The BCL-2 family member BID plays a role during embryonic development in addition to its BH3-only protein function by acting in parallel to BAX, BAK and BOK

Francine S. Ke, Steven Holloway, Rachel T. Uren, Agnes W. Wong, Melissa H. Little, Ruth M. Kluck, Anne K. Voss, Andreas Strasser

Summary: BID functions as an effector of the intrinsic apoptosis pathway, playing a role both upstream and parallel to BAX, BAK, and BOK, and it may exert its function by releasing cytochrome c.

EMBO JOURNAL (2022)

添加到收藏夹

Article Virology

Infectious Spleen and Kidney Necrosis Virus (ISKNV) Triggers Mitochondria-Mediated Dynamic Interaction Signals via an Imbalance of Bax/Bak over Bcl-2/Bcl-xL in Fish Cells

Pin-Han Chen, Tsai-Ching Hsueh, Jen-Leih Wu, Jiann-Ruey Hong

Summary: This study demonstrates that infectious spleen and kidney necrosis virus (ISKNV) infection can induce host cell death through the regulation of mitochondrial membrane potential. The dynamic interaction between pro-apoptotic and anti-apoptotic members of the Bcl-2 family plays a crucial role in this process.

VIRUSES-BASEL (2022)

添加到收藏夹

Article Hematology

Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells

Hannes Schmid, Emmanuelle M. Ribeiro, Kathy-Ann Secker, Silke Duerr-Stoerzer, Hildegard Keppeler, Ruoyun Dong, Timo Munz, Klaus Schulze-Osthoff, Stephan Hailfinger, Corina Schneidawind, Dominik Schneidawind

Summary: This study found that dendritic cells (DC) in the blood of patients with graft-versus-host disease (GvHD) play a crucial role in activating and proliferating T cells. Conversely, transferred iNKT cells inhibit allogeneic reactions of T cells by inducing apoptosis in specific subsets of DC, promoting beneficial immune responses.

HAEMATOLOGICA (2022)

添加到收藏夹

Article Cell Biology

BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment

Stephanie Busche, Katharina John, Franziska Wandrer, Florian W. R. Vondran, Ulrich Lehmann, Heiner Wedemeyer, Frank Essmann, Klaus Schulze-Osthoff, Heike Bantel

Summary: Anti-angiogenic immune checkpoint inhibitor-based combination therapy and tyrosine-kinase inhibitors like sorafenib are treatment options for hepatocellular carcinoma (HCC). However, response to these therapies can be enhanced by pro-apoptotic agents targeting specific BH3-only proteins. Individual profiling of BH3-only protein expression may help stratify patients for TKI-based HCC therapies.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Article Oncology

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

Peter Horak, Christoph Heining, Simon Kreutzfeldt, Barbara Hutter, Andreas Mock, Jennifer Huellein, Martina Froehlich, Sebastian Uhrig, Arne Jahn, Andreas Rump, Laura Gieldon, Lino Moehrmann, Dorothea Hanf, Veronica Teleanu, Christoph E. Heilig, Daniel B. Lipka, Michael Allgaeuer, Leo Ruhnke, Andreas Lassmann, Volker Endris, Olaf Neumann, Roland Penzel, Katja Beck, Daniela Richter, Ulrike Winter, Stephan Wolf, Katrin Pfuetze, Christina Geoerg, Bettina Meissburger, Ivo Buchhalter, Marinela Augustin, Walter E. Aulitzky, Peter Hohenberger, Matthias Kroiss, Peter Schirmacher, Richard F. Schlenk, Ulrich Keilholz, Frederick Klauschen, Gunnar Folprecht, Sebastian Bauer, Jens Thomas Siveke, Christian H. Brandts, Thomas Kindler, Melanie Boerries, Anna L. Illert, Nikolas von Bubnoff, Philipp J. Jost, Karsten Spiekermann, Michael Bitzer, Klaus Schulze-Osthoff, Christof von Kalle, Barbara Klink, Benedikt Brors, Albrecht Stenzinger, Evelin Schroeck, Daniel Huebschmann, Wilko Weichert, Hanno Glimm, Stefan Froehling

Summary: Comprehensive molecular analysis in rare cancers can lead to evidence-based management recommendations and significantly improved clinical outcomes, paving the way for future clinical trials and potentially improving access to experimental treatments for this underserved patient population.

CANCER DISCOVERY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Paracaspase MALT1 in Cancer

Beatriz Gomez Solsona, Anja Schmitt, Klaus Schulze-Osthoff, Stephan Hailfinger

Summary: The paracaspase MALT1 plays a crucial role in immune system and its deregulated activity is associated with cancer. Pharmacological targeting of MALT1 may represent a promising anti-cancer strategy.

BIOMEDICINES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy

Thomas Fischer, Oliver Hartmann, Michaela Reissland, Cristian Prieto-Garcia, Kevin Klann, Nikolett Pahor, Christina Schuelein-Voelk, Apoorva Baluapuri, Bulent Polat, Arya Abazari, Elena Gerhard-Hartmann, Hans-Georg Kopp, Frank Essmann, Mathias Rosenfeldt, Christian Muench, Michael Flentje, Markus E. Diefenbacher

Summary: Loss of PTEN leads to increased resistance of lung cancer cells to radiation therapy, but with significant dependence on ATM kinase. Inhibition of ATM can restore sensitivity to radiation therapy and synergize with it.

CELL AND BIOSCIENCE (2022)

添加到收藏夹

Article Cell Biology

The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA

Sandra Weller, Astrid Toenniessen, Benjamin Schaefer, Tobias Beigl, Alina Muenchow, Kathrin Bopple, Ute Hofmann, Bernhard F. Gillissen, Walter E. Aulitzky, Hans-Georg Kopp, Frank Essmann

Summary: The BCL-2 inhibitor ABT-199 enhances its anti-tumor effect by blocking BCL-2 and inhibiting MCL-1 through the activation of NOXA. This finding suggests the potential of combining ABT-199 with other drugs for improved cancer treatment.

CELL DEATH DISCOVERY (2022)

添加到收藏夹

Article Medicine, General & Internal

Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4

Katharina John, Martin Franck, Sherin Al Aoua, Monika Rau, Yvonne Huber, Joern M. Schattenberg, Andreas Geier, Matthias J. Bahr, Heiner Wedemeyer, Klaus Schulze-Osthoff, Heike Bantel

Summary: The combination of FIB-4 and M30 allows for a more reliable identification of patients at risk for progressed NAFLD and has the potential to improve patient stratification.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Oncology

Gene expression-based prediction of pazopanib efficacy in sarcoma

Christoph E. Heilig, Andreas Lassmann, Sadaf S. Mughal, Andreas Mock, Sebastian Pirmann, Veronica Teleanu, Marcus Renner, Carolin Andresen, Bruno C. Kohler, Bogac Aybey, Sebastian Bauer, Jens T. Siveke, Rainer Hamacher, Gunnar Folprecht, Stephan Richter, Evelin Schrock, Christian H. Brandts, Marit Ahrens, Peter Hohenberger, Gerlinde Egerer, Thomas Kindler, Melanie Boerries, Anna L. Illert, Nikolas von Bubnoff, Leonidas Apostolidis, Philipp J. Jost, C. Benedikt Westphalen, Wilko Weichert, Ulrich Keilholz, Frederick Klauschen, Katja Beck, Ulrike Winter, Daniela Richter, Lino Mohrmann, Michael Bitzer, Klaus Schulze-Osthoff, Benedikt Brors, Gunhild Mechtersheimer, Simon Kreutzfeldt, Christoph Heining, Daniel B. Lipka, Albrecht Stenzinger, Richard F. Schlenk, Peter Horak, Hanno Glimm, Daniel Hubschmann, Stefan Frohling

Summary: The expression levels of NTRK3, IGF1R, and KDR genes are associated with progression-free survival in patients with sarcoma treated with pazopanib. A pazopanib efficacy predictor can be developed based on the expression levels of these genes to accurately predict treatment outcomes for patients.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma

Paula Hoffmeister-Wittmann, Andreas Mock, Federico Nichetti, Felix Korell, Christop E. Heilig, Anna-Lena Scherr, Michael Gunther, Thomas Albrecht, Eblina Kelmendi, Kaiyu Xu, Luisa Nader, Annika Kessler, Nathalie Schmitt, Sarah Fritzsche, Sofia Weiler, Benjamin Sobol, Albrecht Stenzinger, Stefan Boeck, Christoph B. Westphalen, Klaus Schulze-Osthoff, Jorg Trojan, Thomas Kindler, Wilko Weichert, Karsten Spiekermann, Michael Bitzer, Gunnar Folprecht, Anna-Lena Illert, Melanie Boerries, Frederick Klauschen, Sebastian Ochsenreiter, Jens Siveke, Sebastian Bauer, Hanno Glimm, Benedikt Brors, Jennifer Huellein, Daniel Huebschmann, Sebastian Uhrig, Peter Horak, Simon Kreutzfeld, Jesus M. Banales, Christoph Springfeld, Dirk Jaeger, Peter Schirmacher, Stephanie Roessler, Steffen Ormanns, Benjamin Goeppert, Stefan Froehling, Bruno C. Koehler

Summary: The study identified Bcl-x(L) as a key protein in cell death resistance of CCA and suggested its potential prognostic value, serving as a potential therapeutic target.

LIVER INTERNATIONAL (2022)

添加到收藏夹

Article Oncology

Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins

Sophia Steinlein, Frank Essmann, Amanda Franceschini Ghilardi, Heike Horn, Julia Schueler, Angelika Hausser, Lijun Sun, German Ott, Claudia Kalla

Summary: In this study, two indolyl-chalcones (CIT-026 and CIT-223) were found to be highly effective in inhibiting the growth and viability of malignant pleural mesothelioma (MPM) cells, while having minimal effects on normal fibroblasts. These compounds induce tumor cell apoptosis by disrupting microtubule assembly and show promising potential as small-molecule therapeutics for MPM, especially in cells resistant to standard therapeutics.

FRONTIERS IN ONCOLOGY (2023)

添加到收藏夹

Meeting Abstract Oncology

Impact of proteasome inhibitor specificity and efficacy on apoptosis induction by combination with ABT-199.

Sandra Weller, Benjamin Schaefer, Tobias Beigl, Kathrin Boepple, Walter E. Aulitzky, Hans-Georg Kopp, Frank Essmann

CANCER RESEARCH (2021)

添加到收藏夹

Meeting Abstract Oncology

Multi-omics to edge into precision medicine for DIPG.

Sandra Weller, Benjamin Schaefer, Tobias Beigl, Kathrin Boepple, Walter E. Aulitzky, Hans-Georg Kopp, Frank Essmann

CANCER RESEARCH (2021)

添加到收藏夹

Meeting Abstract Oncology

Nascent proteome analysis of tumor cells and their microenvironment in cultured human tumor tissues.

Meng Dong, Karim Aljakouch, Kathrin Boepple, Bernd Winkler, Julia Schueler, Frank Essmann, Hans-Georg Kopp, Jeroen Krijgsveld, Walter E. Aulitzky

CANCER RESEARCH (2021)

添加到收藏夹

Meeting Abstract Oncology

Brought to light: the homotypic interaction pattern of Bcl-2 effector transmembrane domains in a bimolecular luciferase complementation assay.

Tobias B. Beigl, Sandra Weller, Benjamin Schaefer, Kathrin Boepple, Lara-Sophie Rieder, Hans-Georg Kopp, Markus Rehm, Walter E. Aulitzky, Frank Essmann

CANCER RESEARCH (2021)

添加到收藏夹

Article Dermatology

IκBζ is a Key Regulator of Tumour Necrosis Factor-α and Interleukin-17A-mediated Induction of Interleukin-36γ in Human Keratinocytes

Sofie Kaas Ovesen, Klaus Schulze-Osthoff, Lars Iversen, Claus Johansen

Summary: This study reveals a novel crucial regulatory mechanism by which TNF alpha and IL-17A cooperate to regulate the expression of IL-36 gamma in psoriasis, involving the key regulator NFKBIZ and signaling pathways including NF-kappa B, p38 mitogen-activated protein kinase, and ERK1/2.

ACTA DERMATO-VENEREOLOGICA (2021)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.